Flavoxate Hydrochloride Tablets Market to Witness Significant Growth, Owing to High Prevalence of Urinary Incontinence
Flavoxate HCL is a synthetic urinary tract spasmolytic used to treat bladder symptoms such as frequent or urgent urination, increased nighttime urination, bladder pain, and incontinence (urine leakage). According to International Continence Society, in 2018, 63 million people suffered from urgency urinary incontinence worldwide. Such high prevalence of incontinence is expected to aid in growth of the flavoxate hydrochloride tablets market. High prevalence of urinary tract infections (UTIs) is also expected to aid in growth of the flavoxate hydrochloride tablets market. According to the study “Prevalence of Bacterial Urinary Tract Infections and Associated Factors among Patients Attending Hospitals in Bushenyi District, Uganda”, published in February 2019, the prevalence of UTI was 32.2% among the study. Flavoxate HCL is commonly used to treat conditions such as prostatitis, UTIs, and incontinence. The active ingredient is flavonoid glycoside A, which helps by reducing urine...